These effects, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 support the principle of concentrating on ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opioid-connected disorders. Disclaimer: The above can be https://spirob283ypf8.wikicorrespondent.com/user